| End-of-life care preferences of pediatric patients with cancer PS Hinds, D Drew, LL Oakes, M Fouladi, SL Spunt, C Church, WL Furman J Clin Oncol 23 (36), 9146-9154, 2005 | 391 | 2005 |
| Soft tissue sarcoma across the age spectrum: a population‐based study from the surveillance epidemiology and end results database A Ferrari, I Sultan, TT Huang, C Rodriguez‐Galindo, A Shehadeh, ... Pediatric blood & cancer 57 (6), 943-949, 2011 | 343 | 2011 |
| Targeting oxidative stress in embryonal rhabdomyosarcoma X Chen, E Stewart, AA Shelat, C Qu, A Bahrami, M Hatley, G Wu, ... Cancer cell 24 (6), 710-724, 2013 | 319 | 2013 |
| “Trying to be a good parent” as defined by interviews with parents who made phase I, terminal care, and resuscitation decisions for their children PS Hinds, LL Oakes, J Hicks, B Powell, DK Srivastava, SL Spunt, ... Journal of Clinical Oncology 27 (35), 5979, 2009 | 314 | 2009 |
| Genome-informed targeted therapy for osteosarcoma LC Sayles, MR Breese, AL Koehne, SG Leung, AG Lee, HY Liu, ... Cancer discovery 9 (1), 46-63, 2019 | 293 | 2019 |
| Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study DM Green, W Liu, WH Kutteh, RW Ke, KC Shelton, CA Sklar, ... The Lancet Oncology 15 (11), 1215-1223, 2014 | 291 | 2014 |
| Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies C Rodríguez‐Galindo, T Liu, MJ Krasin, J Wu, CA Billups, NC Daw, ... Cancer 110 (2), 375-384, 2007 | 266 | 2007 |
| Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study MM Hudson, KK Ness, VG Nolan, GT Armstrong, DM Green, EB Morris, ... Pediatric blood & cancer 56 (5), 825-836, 2011 | 260 | 2011 |
| Treatment of Ewing sarcoma family of tumors: current status and outlook for the future C Rodriguez‐Galindo, SL Spunt, AS Pappo Medical and pediatric oncology 40 (5), 276-287, 2003 | 244 | 2003 |
| Colorectal carcinoma in childhood and adolescence: a clinicopathologic review DA Hill, WL Furman, CA Billups, SE Riedley, AM Cain, BN Rao, CB Pratt, ... Journal of clinical oncology 25 (36), 5808-5814, 2007 | 214 | 2007 |
| PET/CT in the evaluation of childhood sarcomas MB McCarville, R Christie, NC Daw, SL Spunt, SC Kaste American Journal of Roentgenology 184 (4), 1293-1304, 2005 | 193 | 2005 |
| Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas DS Hawkins, SL Spunt, SX Skapek, COG Soft Tissue Sarcoma Committee Pediatric blood & cancer 60 (6), 1001-1008, 2013 | 185 | 2013 |
| Phase I study of everolimus in pediatric patients with refractory solid tumors M Fouladi, F Laningham, J Wu, MA O'Shaughnessy, K Molina, ... Journal of clinical oncology 25 (30), 4806-4812, 2007 | 184 | 2007 |
| Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's … SL Spunt, CA Poquette, YS Hurt, AM Cain, BN Rao, TE Merchant, ... Journal of clinical oncology 17 (12), 3697-3705, 1999 | 176 | 1999 |
| Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group DP Jones, SL Spunt, D Green, JE Springate Pediatric blood & cancer 51 (6), 724-731, 2008 | 173 | 2008 |
| Pulmonary outcomes in survivors of childhood cancer: a systematic review TT Huang, MM Hudson, DC Stokes, MJ Krasin, SL Spunt, KK Ness Chest 140 (4), 881-901, 2011 | 166 | 2011 |
| Rhabdomyosarcoma in pediatric patients: the good, the bad, and the unusual MB McCarville, SL Spunt, AS Pappo American Journal of Roentgenology 176 (6), 1563-1569, 2001 | 161 | 2001 |
| Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma B Geoerger, MW Kieran, S Grupp, D Perek, J Clancy, M Krygowski, ... European journal of cancer 48 (2), 253-262, 2012 | 151 | 2012 |
| Soft tissue sarcomas of childhood WH Meyer, SL Spunt Cancer treatment reviews 30 (3), 269-280, 2004 | 151 | 2004 |
| Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the … DS Hawkins, YY Chi, JR Anderson, J Tian, CAS Arndt, L Bomgaars, ... Journal of Clinical Oncology 36 (27), 2770, 2018 | 148 | 2018 |
